The Lacritin-Syndecan-1-Heparanase Axis in Dry Eye Disease.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- The Lacritin-Syndecan-1-Heparanase Axis in Dry Eye Disease.
- Published In:
- Advances in experimental medicine and biology, 1221, 747-757 (2020)
- Database ID:
- RPEP-04772
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-04772APA
Dias-Teixeira, Karina; Horton, Xavier; McKown, Robert; Romano, Jeffrey; Laurie, Gordon W. (2020). The Lacritin-Syndecan-1-Heparanase Axis in Dry Eye Disease.. Advances in experimental medicine and biology, 1221, 747-757. https://doi.org/10.1007/978-3-030-34521-1_31
MLA
Dias-Teixeira, Karina, et al. "The Lacritin-Syndecan-1-Heparanase Axis in Dry Eye Disease.." Advances in experimental medicine and biology, 2020. https://doi.org/10.1007/978-3-030-34521-1_31
RethinkPeptides
RethinkPeptides Research Database. "The Lacritin-Syndecan-1-Heparanase Axis in Dry Eye Disease." RPEP-04772. Retrieved from https://rethinkpeptides.com/research/dias-teixeira-2020-the-lacritinsyndecan1heparanase-axis-in
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.